Juvia Group

About Juvia Group

Founded in 2026 by seasoned investors, operators, and entrepreneurs, together we form a generational investing firm to turn access, analysis, and action into breakthrough medicines. Our team has supported more than 25 FDA-approved therapeutics, 20 IPOs, raised over $15 billion in capital, and achieved eight multi-billion-dollar M&A exits. Alongside our Science Partners, who have discovered and developed some of today's most important therapies, we back the teams who pursue bold science to make meaningful medicines. Together, we can turn ambitious ideas into the next generation of medical breakthroughs.
People
  • Stefan Vitorovic, Co-Founder & Managing Director